1 Nov

CF Industries Reported Strong Third-Quarter Earnings

WRITTEN BY Adam Jones

CF Industries’ third-quarter earnings

On October 31, CF Industries (CF) reported its third-quarter earnings. The company reported revenue growth of 19.5% YoY (year-over-year) to $1.04 billion. According to CF Industries, the revenues were mainly driven by nitrogen fertilizers’ higher average selling prices. However, the company stated that the sales volume was lower compared to the same period in 2017.

CF Industries Reported Strong Third-Quarter Earnings

Margins expanded

As a result of the revenue growth, the margins also improved YoY. The gross margins expanded to 16.6% from 1.3% in the third quarter of 2017. The adjusted EBITDA margins expanded to 28.9% from 15.4% in the third quarter of 2017. CF Industries’ EPS rose to $0.13 from a loss per share of $0.37 in the third quarter of 2017.

Stocks reacted

On October 31, CF Industries stock rose 3.9% to $48. However, the stock was trading slightly lower in the after-hours session. Mosaic (MOS) rose by 50 basis points, while Nutrien (NTR) stock gained 2.2%. Israel Chemicals (ICL) was almost flat during the day. These companies (MOO) are set to report their earnings in the coming weeks. Stay tuned!

Latest articles

On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?

Prohibition Partners expects that by 2024, the legal cannabis market could reach $103.9 billion and the medical cannabis market could reach $62.6 billion.

The cannabis sector was trading in the red today. MKM Partners lowered its revenue estimates for Canopy Growth (CGC) (WEED) and Aurora Cannabis (ACB).

Ford plans to unveil its crossover SUV, the Mach-E, on November 17. Ford committed $11.5 billion toward the electrification of its fleet through 2022.

This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it's illegal in Kansas. Even having a small amount is considered a crime.